Andrew Scott
La Trobe University - ONJCRI Node Director
Prof. Andrew Scott leads the Tumour Targeting Program at the Olivia Newton-John Cancer Research Institute and co-Director, Centre for Research Excellence in Brain Tumours; is Director, Department of Molecular Imaging and Therapy, Austin Health; and is Professor, La Trobe University University of and Melbourne.
His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer (particularly with monoclonal antibodies), molecular imaging in oncology, and global advocacy in Oncology and Nuclear Medicine. His laboratory has been involved in the preclinical development and first-in-man trials of numerous recombinant antibodies in cancer patients, and seven antibodies developed in his laboratory have been licenced to Biotech and Pharma companies, and have entered Phase I/II/III trials. He has published 398 peer reviewed papers and 27 book chapters, is an inventor on 22 patents, and is a founder of a biotech company.
Prof. Scott is a member of the Scientific Advisory Committee for the National Imaging Facility, a member of the Scientific Committee of ARTnet, and Federal Council member of the Australian and New Zealand Society of Nuclear Medicine. In 2017 he was awarded Member (AM) in the General Division of the Order of Australia, and elected a Fellow of the Australian Academy of Health and Medical Sciences.
Related News
Radiotherapy and Theranostics: A Lancet Oncology Commission
The Lancet Oncology Commission Report on Radiotherapy and Theranostics, co-led by Professor Andrew Scott AM, La Trobe University and Olivia Newton-John Cancer Research Institute NIF Node Director, and
07 October 2024
National Imaging Facility granted $28m NCRIS funding to strengthen Australia’s advanced imaging network and bolster health research
The Commonwealth Government Department of Education has today announced National Imaging Facility (NIF) will receive $28m under the National Collaborative Research Infrastructure Strategy (NCRIS), to
19 October 2023
Victorian collaboration raises over $50m investment in critical imaging capabilities
The Victorian Government has invested $14.83m in National Imaging Facility’s (NIF) research infrastructure in Victoria, in partnership with the Victorian Biomedical Imaging Capability (VBIC), equati
04 July 2023
Australian cancer patients to benefit from state-of-the-art ACRF Centre for Precision Medicine at the Olivia Newton-John Cancer Research Institute
A new world-class radiochemistry lab will open at the Olivia Newton-John Cancer Research Institute (ONJCRI) to enable access to innovative cancer therapies for Australians.
18 December 2022